• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫唑嘌呤治疗对肾移植患者平均红细胞体积的影响:长期红细胞生成动力学改变的证据。

Effects of azathioprine therapy on the MCV of patients with renal grafts: evidence for alterations in the kinetics of erythropoiesis over a prolonged period.

作者信息

Williams D, Wickramasinghe S N, Hulme B

出版信息

Scand J Haematol. 1978 Mar;20(3):258-64. doi: 10.1111/j.1600-0609.1978.tb02455.x.

DOI:10.1111/j.1600-0609.1978.tb02455.x
PMID:347563
Abstract

The changes in MCV at various times after renal transplantation were studied in a group of patients with functioning cadaveric renal grafts who had received azathioprine from the time of transplantation and in a constant dose from 2-8 weeks later. A post-transplantation increase in the MCV was seen in the majority of the cases studied and in these cases the MCV did not reach a maximum value until as long as 11-40 months after transplantation. In most cases the MCV then feel although frequently not to within the normal range and in some cases it showed further fluctuations. These data suggest gradual alterations over a period of years in the various cytokinetic changes which serve to maintain a reasonably high output of red cells from the marrow despite the cytotoxic effects of azathioprine.

摘要

对一组接受尸体肾移植且移植后即开始使用硫唑嘌呤并从2至8周后开始维持恒定剂量的患者,研究了肾移植后不同时间平均红细胞体积(MCV)的变化。在所研究的大多数病例中,移植后出现了MCV升高,并且在这些病例中,MCV直到移植后长达11至40个月才达到最大值。在大多数情况下,随后MCV下降,尽管常常未降至正常范围内,并且在某些情况下还出现了进一步波动。这些数据表明,尽管硫唑嘌呤具有细胞毒性作用,但在数年时间里各种细胞动力学变化会逐渐改变,以维持骨髓中红细胞的合理高输出量。

相似文献

1
Effects of azathioprine therapy on the MCV of patients with renal grafts: evidence for alterations in the kinetics of erythropoiesis over a prolonged period.硫唑嘌呤治疗对肾移植患者平均红细胞体积的影响:长期红细胞生成动力学改变的证据。
Scand J Haematol. 1978 Mar;20(3):258-64. doi: 10.1111/j.1600-0609.1978.tb02455.x.
2
Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients.硫唑嘌呤和霉酚酸酯免疫抑制方案对肾移植受者红细胞生成系统的影响。
Transplant Proc. 2006 Sep;38(7):2077-9. doi: 10.1016/j.transproceed.2006.06.043.
3
Erythroid toxicity of azathioprin. Macrocytosis and selective marrow hypoplasis.
Q J Med. 1975 Jan;44(173):57-63.
4
Observations on the incidence and cause of macrocytosis in patients on azathioprine therapy following renal transplantation.肾移植后接受硫唑嘌呤治疗患者大细胞增多症的发病率及病因观察
Transplantation. 1974 Nov;18(5):443-6. doi: 10.1097/00007890-197411000-00009.
5
Bone marrow morphology in patients in long-term treatment with azathioprine.接受硫唑嘌呤长期治疗患者的骨髓形态学
Scand J Haematol. 1981 Mar;26(3):182-6. doi: 10.1111/j.1600-0609.1981.tb01645.x.
6
Hematologic side effects of azathioprine and mycophenolate in kidney transplantation.硫唑嘌呤和霉酚酸酯在肾移植中的血液学副作用。
Transplant Proc. 2011 Mar;43(2):504-6. doi: 10.1016/j.transproceed.2011.01.077.
7
Azathioprine-induced pure red blood cell aplasia.
JAMA. 1978 Aug 11;240(6):552-4.
8
Development of macrocytosis during azathioprine therapy after renal transplantation. A correlation of renal function with MCV.肾移植后硫唑嘌呤治疗期间大细胞性贫血的发生。肾功能与平均红细胞体积的相关性。
Transplantation. 1979 Mar;27(3):220-1.
9
Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.在接受环孢素治疗的患者中,添加硫唑嘌呤可改善慢性肾移植功能障碍。
Transplantation. 1989 Feb;47(2):249-54. doi: 10.1097/00007890-198902000-00010.
10
Effect of cyclosporine and delayed graft function on posttransplantation erythropoiesis.
Transplantation. 1985 Dec;40(6):624-31. doi: 10.1097/00007890-198512000-00010.

引用本文的文献

1
Reversible azathioprine-induced erythrocyte aplasia in a renal transplant recipient.肾移植受者中可逆性硫唑嘌呤诱导的红细胞再生障碍
Can Med Assoc J. 1982 Mar 1;126(5):512-3.
2
Erythropoiesis and erythropoietin levels in renal transplant recipients.
Klin Wochenschr. 1991 Jan 22;69(2):53-8. doi: 10.1007/BF01666817.